UPDATE May 22: This morning the company announced the postponement of their IPO. As we noted during marketing this company doesn't have a tight enough positioning and roadshow presentation to attract investors. Some of our thoughts on how they might reshape their story are below but we're not sure management will hear the message or just suppose that the reason their deal couldn't get done is just general market weakness.
Despite the bold title this cancer care provider is only getting limited interest in their IPO. Part of the reason is their balance sheet which includes debt . . .